Fig. 3From: In vivo immunogenicity assessment and vaccine efficacy evaluation of a chimeric tandem repeat of epitopic region of OMP31 antigen fused to interleukin 2 (IL-2) against Brucella melitensis in BALB/c miceTiter of total IgG. Total IgG against RevI vaccine (a), rOmp31 protein (b) and r3E protein (c) in different dilution of sera (1/50–1/6400) at OD 405 nmBack to article page